Accelerated partial breast irradiation in early stage breast cancer

Paulina E. Galavis, Camille Hardy Abeloos, Pine C. Cheng, Christine Hitchen, Allison McCarthy, Juhi M. Purswani, Bhartesh Shah, Sameer Taneja, Naamit K. Gerber

Research output: Contribution to journalReview articlepeer-review


Accelerated partial breast irradiation (APBI) is increasingly used to treat select patients with early stage breast cancer. However, radiation technique, dose and fractionation as well as eligibility criteria differ between studies. This has led to controversy surrounding appropriate patients for APBI and an assessment of the toxicity and cosmetic outcomes of APBI as compared to whole breast irradiation (WBI). This paper reviews existing data for APBI, APBI delivery at our institution, and ongoing research to better define patient selection, treatment delivery, dosimetric considerations and toxicity outcomes.

Original languageEnglish (US)
Article number1049704
JournalFrontiers in Oncology
StatePublished - Nov 10 2022


  • accelerated partial breast irradiation
  • dosimetric considerations
  • early stage breast cancer
  • toxicity outcomes
  • treatment planning

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Accelerated partial breast irradiation in early stage breast cancer'. Together they form a unique fingerprint.

Cite this